Inhibiting VEGF‐B reconstitutes membrane cholesterol levels and restores glucose uptake.[106] It will be interesting to evaluate if VEGF‐B inhibition via clinically approved drugs, such as simvastatin, can rescue transcytosis of Aβ clearance to promote AD treatment. This evidence concerns the gene VEGFB and Alzheimer disease.